PRO-DEX, INC. Effective Income Tax Rate Reconciliation Beat Percent
PRO-DEX, INC. (PDEX) reported Effective Income Tax Rate Reconciliation Beat Percent of 26.00% for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationBeatPercent · last filed 2026-04-30
- PRO-DEX, INC. effective income tax rate reconciliation beat percent for the quarter ending 2026-03-31 was 26.00%, a 7.14% decline year-over-year.
- PRO-DEX, INC. effective income tax rate reconciliation beat percent for the quarter ending 2025-12-31 was 25.00%, a 19.05% increase year-over-year.
- PRO-DEX, INC. effective income tax rate reconciliation beat percent for the quarter ending 2025-09-30 was 25.00%, a 3.85% decline year-over-year.
- PRO-DEX, INC. effective income tax rate reconciliation beat percent for the quarter ending 2025-03-31 was 28.00%, a 0.00% change year-over-year.
| Period end | Effective Income Tax Rate Reconciliation Beat Percent 3 month | Effective Income Tax Rate Reconciliation Beat Percent 6 month | Effective Income Tax Rate Reconciliation Beat Percent 9 month |
|---|---|---|---|
| 2026-03-31 | 26.00% 10-Q · filed 2026-04-30 | 25.00% 10-Q · filed 2026-04-30 | |
| 2025-12-31 | 25.00% 10-Q · filed 2026-01-29 | 25.00% 10-Q · filed 2026-01-29 | |
| 2025-09-30 | 25.00% 10-Q · filed 2025-10-30 | ||
| 2025-03-31 | 28.00% 10-Q · filed 2026-04-30 | 26.00% 10-Q · filed 2026-04-30 | |
| 2024-12-31 | 21.00% 10-Q · filed 2026-01-29 | 24.00% 10-Q · filed 2026-01-29 | |
| 2024-09-30 | 26.00% 10-Q · filed 2025-10-30 | ||
| 2024-03-31 | 28.00% 10-Q · filed 2025-05-01 | 23.00% 10-Q · filed 2025-05-01 | |
| 2023-12-31 | 19.00% 10-Q · filed 2025-01-30 | 45.00% 10-Q · filed 2025-01-30 | |
| 2023-09-30 | 26.00% 10-Q · filed 2024-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |